Novotech initiates cancer trials in Australia and New Zealand for Oncomed Pharmaceuticals

NOVOTECH  INITIATES PHASE IB CANCER TRIALS IN AUSTRALIA AND NEW ZEALAND FOR CLIENT, ONCOMED PHARMACEUTICALS Sydney, Australia, 29 October 2010 – Novotech has announced initiation of three Phase Ib oncology trials at sites in Australia and New Zealand to test the safety, efficacy and pharmacokinetics of client OncoMed’s humanized monoclonal antibody product designed to target [...]

Novotech Selects Oracle’s Siebel Clinical Trial Management System to Support Continued Growth

Novotech Selects Oracle’s Siebel Clinical Trial Management System to Support Continued Growth Sydney, Australia – 27 October, 2010 News Facts Novotech, the largest independent clinical research organisation in Australia, has selected Oracle’s Siebel Clinical Trial Management System to support the company’s complete spectrum of clinical drug development and research. Novotech works with leading biotechnology and [...]

iTnews

Novotech runs clinical trials on Oracle  A group of three Phase I trials being run by local CRO Novotech is casting a wide net for OncoMed’s cancer-fighting humanised monoclonal antibody OMP-21M18. Novotech has announced that it will license about $500,000 of Oracle Siebel software to help manage clinical research trials at 400 hospitals and health [...]

Outsourcing Pharma

Podcast: Asia Pacific trial sector poised for continued growth, says Novotech The Asia Pacific trial sector grew during the global economic downturn as sponsors sought to improve access to patients, cut costs and improve data quality according to Novotech CEO Alek Safarian.   Outsourcing Pharma Podcast For a licensed copy [CAL] of this article please [...]

Trials In Focus

Inside Stories – Wide brief for cancer candidate A group of three Phase I trials being run by local CRO Novotech is casting a wide net for OncoMed’s cancer-fighting humanised monoclonal antibody OMP-21M18. The aim of all three trials is to determine the safety, efficacy, pharmacokinetics and maximum tolerated dose of OMR-21M18 when combined with [...]

Trials In Focus

Inside Stories – Asian trial growth creates hurdles Despite rapid growth in clinical trial activity across Asia, sponsors and CROs need to take care in managing unfamiliar environments says the CEO of Australian-based CRO, Novotech. Alek Safarian told the 46th annual meeting of the Drug Information Association (DIA) in Washington DC last week that regulatory [...]

Novotech announces four country Asia expansion at AusBiotech 2009

NOVOTECH ANNOUNCES FOUR COUNTRY ASIA EXPANSION AT AUSBIOTECH 2009 New operations in Malaysia, Singapore, Thailand, and Philippines Sydney, Oct 27, 2009 – Leading Australian contract clinical research company Novotech announced today that it was expanding into four new Asian markets with the establishment of a management hub in Kuala Lumpur, Malaysia. Novotech CEO Alek Safarian [...]

BioTechnology News

Novotech expands presence in Asia Unlisted Australian contract research organisation Novotech is continuing its aggressive Asian expansion plans, announcing yesterday it will establish a regional management hub in Malaysia and a presence in Singapore, Thailand and the Philippines. Novotech, which has had a bumper year despite the economic downturn, according to chief executive Alek Safarian, [...]

Trials In Focus

New Asia hub for Novotech Australian-based CRO Novotech is expanding into four new Asian markets with the establishment of a management hub in Kuala Lumpur. The hub will cover Novotech’s presence in Singapore, Thailand and the Philippines, adding to a joint venture presence in India and an office in Korea. “A sizeable patient population, transparent [...]

Novotech wins coveted Australian CRO Award from Frost & Sullivan

San Diego, CA– June 19, 2008 — Novotech, the largest Australian owned contract research organization (CRO) has confirmed its position as the pre-eminent Australian based CRO with the award by leading industry analyst house Frost & Sullivan as the Australian CRO of the Year. The award is part of the prestigious Excellence in Healthcare Awards [...]

Next Page »